Nestor

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Nestor

Quick Facts: Nestor (Rosuvastatin)

Property Description
Active ingredient Rosuvastatin (typically as Rosuvastatin Calcium)
Form Tablet (oral)
Pharmacological class Statin (HMG-CoA reductase inhibitor)
Common use Management of high cholesterol (dyslipidemia)
Origin Synthetic compound

What Type of Medicine is Nestor and What is it Made Of?

Nestor is a prescription-only, synthetic medicine containing the active ingredient Rosuvastatin, and is classified in the pharmacological class known as statins. This medicine is technically an HMG-CoA reductase inhibitor, delivered as a single-ingredient product in a solid tablet form for oral administration. The classification is essential for defining its role in cardiovascular care.

The core of the product is Rosuvastatin, a compound developed through chemical synthesis. Its mechanism is defined as an HMG-CoA reductase inhibitor that acts in the liver. The drug's action is fundamentally based on slowing the body's internal cholesterol production. As an oral therapy, the tablet formulation ensures a precise and convenient method for delivering the medication.


What is the General Purpose of Taking Nestor?

The general purpose of Nestor is to assist in regulating and normalizing levels of circulating fats in the blood, primarily treating high levels of cholesterol and dyslipidemia. It achieves this by conceptually slowing down the body’s self-production of cholesterol within the liver.

The primary therapeutic aim is the significant reduction of Low-Density Lipoprotein Cholesterol (LDL-C), commonly referred to as "bad cholesterol." Clinical data consistently shows the efficacy of Rosuvastatin in reducing LDL-C and its positive impact on cardiovascular risk. This evidence demonstrates that the medication is effective in controlling blood fat levels. By helping to maintain healthier blood fat levels, the medication serves as a core preventative strategy aimed at mitigating cardiovascular risks and supporting long-term cardiovascular health.

Regulatory References

  1. MedlinePlus Drug Information
  2. U.S. National Institutes of Health
  3. NIH LiverTox

What side effects are possible with Nestor?

Possible Side Effects and Safety Information for Nestor

Nestor (a product containing the active ingredient Atorvastatin, a type of HMG-CoA reductase inhibitor or "statin") is associated with an established safety profile, primarily involving Hepatic and Musculoskeletal system risks.

Adverse Reaction Scope

Category Regulatory Frequency Framework Used
Common Adverse Reactions ( 1/100 to <1/10 ) Nasopharyngitis, arthralgia (joint pain), myalgia (muscle pain), pain in extremities, headache, nausea, diarrhea, dyspepsia, urinary tract infection, and abnormal liver function tests.
Serious Adverse Reactions Clinically significant adverse effects include rhabdomyolysis (severe muscle damage) which can lead to acute renal failure, and hepatic failure (liver problems) sometimes evidenced by jaundice (yellowing of the skin/eyes). Severe hypersensitivity reactions (anaphylaxis) have been reported post-marketing.

Population-Specific Safety Considerations and Restrictions

Pregnancy and Lactation: Use of the active ingredient in Nestor is contraindicated during pregnancy, as it may cause significant harm to the fetus. The drug is also contraindicated in women who are breastfeeding due to the potential for serious adverse reactions in the nursing infant.

Liver Disease: Nestor is contraindicated in individuals with active liver disease or unexplained persistent elevations of serum transaminases (indicators of liver health).

Dose-Related Patterns: The risk of myopathy and rhabdomyolysis is considered dose-related and may be increased with co-administration of certain drugs, including specific antifungal agents, macrolide antibiotics, and HIV protease inhibitors. Caution is advised when prescribing to patients over 65 years of age or those with renal impairment, who may have predisposing factors for myopathy.

Safety Monitoring: Regular monitoring of liver function tests is advised before and periodically during treatment. Patients must be monitored for unexplained muscle pain, tenderness, or weakness, which may be a sign of myopathy or rhabdomyolysis. The drug may also cause an increase in blood glucose levels; diabetic patients should have their blood sugar levels closely monitored.

Overdose and Emergency Response

Nestor Overdose and when to seek help


Overdose Scope: Officially Documented Presentations

The documented experience with Rosuvastatin overdose is limited. The core concern, as detailed in regulatory documents, relates to the potential for severe systemic toxicity, primarily affecting muscle and liver function. Officially documented manifestations that warrant immediate attention include unexplained muscle pain, tenderness, or weakness, particularly if these occur with fever or malaise. Signs of severe hepatic injury, such as jaundice or dark-colored urine, are also recognized as presentations requiring urgent intervention. Physiologically, the critical risk involves Rhabdomyolysis potentially leading to Acute Renal Failure. The risk for adverse outcomes is documented to increase with the maximum dose of 40 mg, and in patients with severe renal impairment.


Emergency Actions Mandated by Regulators

In the event of suspected overdose, regulatory guidance requires that management be strictly symptomatic and supportive. There is no specific antidote known for Rosuvastatin. Furthermore, official labeling indicates that hemodialysis does not significantly enhance clearance of the drug due to its high protein binding. Emergency medical help must be sought immediately if symptoms like severe muscle pain or signs of liver injury develop. Discontinuation of the medication is required if clinical signs of severe toxicity or markedly elevated Creatine Kinase (CK) levels are confirmed. Continuous monitoring of renal and liver function is necessary as part of the official supportive care measures.

Therapeutic Uses of Nestor

What Nestor Treats: Main Uses and Benefits

Nestor may be part of symptomatic management when symptoms intensify and supportive relief is needed to address discomfort caused by an acute onset. In such cases, supportive management of specific symptoms may contribute to maintaining comfort and easing the overall symptom burden during difficult episodes.

This medicine is relevant for easing symptom clusters that may appear suddenly or fluctuate in intensity, a characteristic of conditions involving recurrent or episodic manifestations. It is applied across domains where additional symptomatic support is needed to manage symptoms that interfere with daily comfort and function, including symptoms related to physical discomfort, systemic imbalance, and heightened physiological activity.


Quick Fact: Nestor is commonly used to help with symptoms that intensify temporarily.


When symptoms become more noticeable, Nestor may assist with maintaining functional stability. It may contribute to easing discomfort during periods of heightened symptoms, supports the patient during difficult episodes by easing distress, and is considered relevant for short-term symptomatic assistance.

Regulatory References

  1. BC Government Palliative Care Guidelines on Symptom Management

Eligibility and Restrictions for Use

Nestor (Rosuvastatin) is a prescription medicine with strictly defined population eligibility based on official regulatory documentation. It is permitted for use in adults and for specific hereditary conditions in pediatric patients starting at age 6 to 8 years for Heterozygous Familial Hypercholesterolemia, and at age 7 years for Homozygous Familial Hypercholesterolemia. Use is not established and is not recommended in children younger than 6 years.

Formal Exclusions (Contraindications)

The medicine is formally contraindicated and must not be used in the following populations or clinical states:

Category Restriction
Reproductive Status Women who are pregnant or breastfeeding (lactating mothers). Females of reproductive potential must use effective contraception.
Liver Status Patients with Active Liver Disease or unexplained, persistent elevations of serum transaminases (liver enzymes).
Hypersensitivity Patients with known hypersensitivity or allergy to Rosuvastatin or any components of the drug.
Co-administration Patients receiving concomitant Ciclosporin (Cyclosporine).

Conditional Restrictions

Use is restricted or limited in specific populations. Patients with severe renal impairment have a maximum allowed dose that must not be exceeded. The highest 40 mg dose is contraindicated in patients with severe renal impairment and in Asian patients. Caution is also advised in older adults (ge 65 years) and patients with predisposing factors for myopathy, such as uncontrolled hypothyroidism.

What should I know about interactions with other medicines?

Nestor Interactions with other medicines and products

The interaction profile of Nestor (Rosuvastatin) is defined by its status as a substrate for specific drug transporters, leading to documented pharmacokinetic and pharmacodynamic constraints when co-administered with certain medications.

Interaction Classification Relevant Interacting Substances
Contraindicated Combinations Ciclosporin and certain Hepatitis C Antivirals (e.g., Sofosbuvir/Velpatasvir/Voxilaprevir) are explicitly restricted due to significant increases in Rosuvastatin exposure.
Transporter-Mediated Exposure Increase Gemfibrozil, Darolutamide, and certain HIV Antivirals (e.g., Lopinavir/Ritonavir) inhibit the OATP1B1 and BCRP transporters, requiring dose limitation or avoidance to mitigate the increased risk of myopathy.
Pharmacodynamic Interactions Coumarin anticoagulants (e.g., Warfarin) prolong the International Normalized Ratio (INR), mandating frequent INR monitoring until stable. Concomitant use with other lipid-lowering therapies (fibrates, high-dose niacin) increases the documented risk of adverse skeletal muscle effects.
Gastrointestinal Absorption Antacids containing aluminum and magnesium hydroxide decrease Rosuvastatin plasma concentration due to reduced absorption. A regulatory timing rule requires the antacid to be administered at least 2 hours after Rosuvastatin.

Rosuvastatin undergoes minimal metabolism via the CYP450 system, but its primary elimination route is susceptible to inhibition by other medicines. Population-specific notes in regulatory documents indicate that patients of Asian descent may experience increased systemic exposure, a factor considered when initiating therapy.

Mechanism of Action

Targeted Inhibition of Cholesterol Synthesis

The molecular mechanism of Rosuvastatin begins with the competitive and reversible inhibition of the HMG-CoA reductase enzyme, primarily in the liver. This enzyme catalyzes the rate-limiting step of the mevalonate pathway, which is central to the body's cholesterol biosynthesis. This specific blockade results in a direct reduction of intracellular cholesterol production.


Enhanced Clearance of Circulating Lipids

The resulting deficiency in intracellular hepatic cholesterol concentration triggers a regulatory feedback mechanism that significantly increases the number of LDL receptors expressed on the hepatocyte surface. This increase enhances the liver’s capacity to pull Low-Density Lipoprotein Cholesterol (LDL-C) and other atherogenic lipids from the bloodstream, leading to a sustained reduction in circulating lipid concentrations.


️ Modulation of Vascular Processes

The drug's mechanism also involves the downstream reduction of isoprenoid intermediates due to mevalonate pathway inhibition. This reduction affects protein prenylation, which in turn modulates cell signaling pathways (e.g., Rho/Rac). This modulation influences the functional state of the vascular endothelium and is associated with a reduction in certain underlying inflammatory biomarkers.

Dosage and Administration Information

How to Use Nestor: Official Administration Guidelines

The administration of Nestor (Rosuvastatin) is defined by official guidelines, establishing clear rules for dose ranges, frequency, and specific intake conditions. The medicine is primarily available as tablets in strengths of 5 mg, 10 mg, 20 mg, and 40 mg of the active ingredient.

Core Usage Protocol

Nestor is administered orally and must be taken as a whole tablet without crushing, dissolving, or chewing. The required frequency is once daily, with the flexibility to be administered with or without food and at any time of day.

Dosage and Adjustment

The standard adult starting dose is typically 10 mg or 20 mg once daily, though a 5 mg starting dose is also utilized. The overall maintenance range spans 5 mg to 40 mg. The 40 mg dose represents the maximum daily amount and is generally reserved for patients who have not achieved adequate goals with the 20 mg dose. Any dosage adjustment, or titration, should be considered only after a minimum period of 2 to 4 weeks following the last change, based on professional assessment of lipid levels.

Specific Administration Conditions

Specific guidelines address certain patient populations: A starting dose of 5 mg is mandated for patients with severe renal impairment (not on hemodialysis), and the dose should not exceed 10 mg once daily in this group. Similarly, a 5 mg starting dose is considered for Asian patients due to pharmacokinetic considerations. If a dose is missed, the patient should not take an extra dose but should resume treatment with the next scheduled dose.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Nestor

This overview describes the types of scientific research conducted on Nestor (Rosuvastatin), what the studies monitored, and what researchers have reported, based on official documents and peer-reviewed scientific literature.


Evidence for Managing High Cholesterol and Cardiovascular Risk

Research on Nestor's use in managing high cholesterol (dyslipidemia) has centered on short-term randomized controlled trials (RCTs). These studies monitored changes in specific lipid biomarkers, primarily Low-Density Lipoprotein Cholesterol (LDL-C), and reported measurements of changes in these levels over the study period.

For reducing cardiovascular risk, research includes a large-scale, long-term, randomized, placebo-controlled outcome trial (JUPITER). This trial examined adults without established coronary heart disease but with multiple risk factors and elevated inflammatory biomarkers. Researchers monitored the occurrence of a composite primary outcome (e.g., nonfatal heart attack or stroke). Reported patterns from the study indicated that the occurrence rate of this composite outcome in the Nestor group showed a different measurement compared to the placebo group.


Evidence in Special Populations and Research Gaps

Research has explored the use of Nestor in children and adolescents with inherited high cholesterol conditions (Familial Hypercholesterolemia). These studies monitored changes in LDL-C and markers of physical development, but often rely on small patient numbers due to the conditions' rarity.

A primary research gap is the reliance on surrogate endpoints (like lipid changes) where limited data are available for tracking hard, long-term clinical events across all study types. Furthermore, due to the main primary prevention trial being terminated early, the long-term effects are not fully established beyond the observation period of that study as documented by regulators. These factors contribute to areas where certainty remains low in the broader research landscape.

Frequently Asked Questions (FAQ)

Common questions about Nestor (FAQ)


Q: How long does one dose of Nestor typically stay active in the body?

A: According to official product information, the time it takes for the amount of Rosuvastatin to reduce by half in the bloodstream, known as the plasma half-life, is reported to be approximately 19 hours. This measurement is one of the factors that supports its once-daily administration.


Q: Can Nestor be taken by people with diabetes?

A: Official documents describe that medicines in this class may lead to an increase in blood glucose (sugar) levels. Regulatory warnings describe that close monitoring of blood sugar levels is advised for patients with diabetes who are using Nestor.


Q: What happens if I miss a dose of Nestor?

A: Regulatory guidance describes the protocol for a missed dose as: do not take an extra dose, but instead resume treatment with the next scheduled dose as usual. This instruction prevents accidentally taking more than the prescribed daily amount.


Q: How often do people need follow-up appointments when taking Nestor?

A: Regulatory instructions state that any dose adjustment, or titration, should be considered only after a minimum period of 2 to 4 weeks. This period is established to allow time for lipid levels to be assessed and for potential dose adjustments to be considered. Official monitoring recommendations include liver function tests periodically throughout treatment.


Q: Can I take Nestor with a small amount of food if it upsets my stomach?

A: The official product information specifies that Nestor has the flexibility to be administered with or without food. This flexibility means that taking it with a small meal or snack is described as not impacting the way the medicine works.


Q: Is Nestor a treatment for pain or an anti-inflammatory drug?

A: Nestor's active ingredient, Rosuvastatin, is officially classified as an HMG-CoA reductase inhibitor, belonging to the statin class of medicines. Its primary documented purpose is to assist in managing high cholesterol (dyslipidemia); it is not classified as a pain treatment or an anti-inflammatory medicine.


Q: Does Nestor have a generic version available?

A: Official guidelines on generic drugs state that the active ingredient in Nestor, Rosuvastatin, has received formal approval as a generic equivalent. This regulatory status allows for other companies to produce generic products containing the same active ingredient, though inactive components may vary.


Q: How quickly should I expect to see an effect after starting Nestor?

A: Studies and official information indicate that a therapeutic response from Nestor is usually seen within 1 week of starting treatment. The maximum effect on lipid levels is generally achieved within 2 to 4 weeks, based on published data.


Q: Is it normal to feel a bit nauseous when first starting Nestor?

A: Nausea is listed in official documents as a common adverse reaction to Nestor. This means that, based on clinical trial data, it has been reported by a measurable number of patients during treatment.


Q: Are the serious side effects of Nestor rare?

A: Serious adverse reactions, such as severe muscle damage (rhabdomyolysis) and liver problems, are documented in official safety information. Regulatory documents classify the frequency of all adverse reactions, which helps define the documented commonality of these effects.


Q: Is Nestor safe to take if I have high blood pressure?

A: According to official product information, high blood pressure is not listed as a formal contraindication (a reason not to take the drug) or as a specific cautionary condition that requires a dose limitation.


Q: Are there any common foods or drinks that interact with Nestor?

A: Regulatory documents have specifically examined potential interactions with grapefruit juice. Official reports state that no clinically significant interaction has been observed between Nestor and grapefruit juice.


Q: Does taking Nestor affect my ability to drive or operate machinery?

A: Official documents often state that based on the drug's mechanism and overall safety profile, Nestor is not expected to affect the ability to drive or operate machines.


Q: Is Nestor considered a controlled substance?

A: Nestor (Rosuvastatin) is a prescription medicine, but it is not classified as a controlled substance by government drug enforcement agencies in the same category as certain narcotic pain medications.


Q: Why are there different strengths or formulations of Nestor?

A: The different strengths (such as 5 mg, 10 mg, 20 mg, and 40 mg) are established in regulatory documents. This range is designed to allow healthcare professionals to select an individualized dose for each patient based on their specific cholesterol reduction goals.


Q: Is Nestor a habit-forming or addictive drug?

A: Official regulatory classifications do not describe Nestor (Rosuvastatin) as a medicine with a potential for abuse or dependence. It is not listed as a habit-forming drug.


Q: Do studies show that Nestor works differently in men versus women?

A: Regulatory documents indicate that clinical trials and data analysis have not found any clinically significant differences in the effectiveness or safety profile of Rosuvastatin reported between male and female patients.


Q: Does the time of day matter when taking Nestor?

A: The official product information specifies that Nestor is flexible. It can be administered once daily at any time of day (morning, afternoon, or evening) without regulatory concerns about timing.


Q: Why is alcohol use discouraged while taking Nestor?

A: Official safety warnings describe that excessive alcohol use may potentially increase the risk of adverse effects on the liver. This warning is in place to manage the overall risk profile related to liver health.


Q: What is the difference between a 'side effect' and a 'drug interaction' for Nestor?

A: A side effect is defined as an unintended bodily response to the drug itself, such as muscle pain or headache. A drug interaction is a change in the drug's effect when it is taken at the same time as another substance, which may potentially alter its safety or effectiveness.


Q: Does Nestor make you drowsy or affect sleep?

A: Drowsiness is generally not listed as a common adverse reaction for this medicine in regulatory documents. The official adverse reaction profile mainly focuses on musculoskeletal, gastrointestinal, and general nervous system effects.


Q: Are there specific tests I need before starting Nestor?

A: Regulatory documents advise that liver function tests are recommended before starting treatment. This monitoring is established to create a baseline of liver health and to assist professionals in assessing overall treatment suitability.


Q: Does Nestor have any known psychological or mood-related side effects?

A: Regulatory documents list common adverse reactions related to the central nervous system, such as headache or dizziness. However, specific psychological or mood disorders are not typically listed as common or serious effects.


Q: Why is it important to tell my doctor about all the medicines I take when starting Nestor?

A: This is important because Nestor has documented and potential drug interactions with certain medicines. These interactions are detailed in the regulatory text and may potentially alter the drug's exposure or effectiveness.


Q: What happens in the body when Nestor is being eliminated?

A: Official pharmacokinetic information describes that Rosuvastatin is primarily eliminated via the faeces (about 90% of the dose). Only a small amount is eliminated through the urine, with minimal metabolism (breakdown) occurring through the main liver enzyme system.


Q: Is Nestor used in combination with other drugs for treatment?

A: Nestor is officially indicated for use as an adjunct (an addition) to diet and other non-pharmacological therapies. This confirms its role as one component in a broader treatment plan for managing high cholesterol when lifestyle measures alone are insufficient.


Q: Do different brands of Nestor contain the exact same ingredients?

A: Official regulatory guidelines state that a generic version must contain the same active ingredient (Rosuvastatin) as the original brand-name drug. However, the different brands or generic products may contain different inactive components, such as fillers or coloring agents.


Q: Why is a specific type of monitoring sometimes recommended while taking Nestor?

A: Monitoring (e.g., liver function tests, muscle symptoms) is recommended because the drug is associated with known potential risks. This monitoring is designed to assist healthcare professionals in identifying potential changes in health markers associated with documented risks, such as potential liver or muscle damage (myopathy).


Q: Can Nestor affect my vision?

A: Vision changes are not typically listed in regulatory documents as a common adverse reaction for this medicine. The official adverse reaction profile mainly focuses on musculoskeletal, gastrointestinal, and general nervous system effects.


Q: How is the dose of Nestor typically adjusted?

A: Dose adjustment is based on a professional assessment of the patient’s lipid levels, not just on symptoms. Regulatory guidelines state that any change to the dose may be considered only after a minimum of 2 to 4 weeks following the last adjustment.


Q: Why is the information in the patient leaflet slightly different from the doctor's document?

A: Regulatory systems require two separate documents: a comprehensive professional label containing highly detailed scientific data for prescribers, and a simplified patient information leaflet that provides clear, accessible safety and usage instructions. They serve different purposes, leading to differences in content detail.

How should Nestor be stored and disposed of?

How to Store and Dispose of Nestor?

Nestor (Rosuvastatin) must be stored and disposed of according to strict official regulations to ensure product integrity and safety.


Storage Requirements

  • Temperature and Protection: Store tablets at controlled room temperature, typically 20 C to 25 C (68 F to 77 F). The container must be kept tightly closed to protect from moisture.
  • Child Safety: It is mandatory to keep the medicine out of the sight and reach of children.

Disposal Instructions

  • Official Protocol: Disposal of unused or expired tablets must be done according to local requirements for pharmaceutical waste.
  • Environmental Restriction: Nestor must not be disposed of via wastewater (flushing) or general household trash to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Nestor found in:

A-Z Index: